Literature DB >> 11257385

Vaccines and mucosal immunisation.

A W Cripps1, J M Kyd, A R Foxwell.   

Abstract

The earliest attempts to protect humans against infectious diseases and toxins were by administering foreign substances to mucosal membranes, predominantly by the oral route. In the late 1880s, significant attention was given to the concept of 'local' immunisation, and the discipline of mucosal immunology was born in the early 1900s. However, despite the early enthusiasm, progress has been slow, with few mucosal vaccines being efficacious. The complexities of mucosal immune regulation and the lack of appropriate antigen delivery systems which can access mucosal inductive sites, have remained substantial obstacles. Recent studies demonstrating compartmentalisation of the common mucosal immune system create further challenges for the development of organ-specific vaccines. In the 21st century, our knowledge of mucosal immunoregulatory mechanisms, coupled with new technology for antigen delivery and immunomodulation will provide the necessary know-how to see the development and widespread use of mucosal vaccines for both preventative and therapeutic use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257385     DOI: 10.1016/s0264-410x(00)00481-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits.

Authors:  Zhengrong Cui; Russell J Mumper
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

2.  Localization of a bacterial protein in starch granules of transgenic maize kernels.

Authors:  Rachel K Chikwamba; M Paul Scott; Lorena B Mejía; Hugh S Mason; Kan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

3.  pH-triggered release of macromolecules from spray-dried polymethacrylate microparticles.

Authors:  Daniel S Kohane; Daniel G Anderson; Christine Yu; Robert Langer
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

4.  The development of an AIDS mucosal vaccine.

Authors:  Xian Tang; Zhiwei Chen
Journal:  Viruses       Date:  2010-01-22       Impact factor: 5.818

5.  Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses.

Authors:  Yan Zhang; Jingyi Yang; Rong Bao; Yaoqing Chen; Dihan Zhou; Benxia He; Maohua Zhong; Yaoming Li; Fang Liu; Qiaoli Li; Yi Yang; Chen Han; Ying Sun; Yuan Cao; Huimin Yan
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

Review 6.  Production of Recombinant Anti-Cancer Vaccines in Plants.

Authors:  Jeong Hwan Lee; Kisung Ko
Journal:  Biomol Ther (Seoul)       Date:  2017-07-01       Impact factor: 4.634

7.  Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection.

Authors:  Wu Li; Guangcun Deng; Min Li; Xiaoming Liu; Yujiong Wang
Journal:  Tuberc Res Treat       Date:  2012-11-01

8.  Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis.

Authors:  Anderson Miyoshi; Luis G Bermúdez-Humarán; Luciana A Ribeiro; Yves Le Loir; Sérgio C Oliveira; Philippe Langella; Vasco Azevedo
Journal:  Microb Cell Fact       Date:  2006-03-23       Impact factor: 5.328

9.  Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity.

Authors:  Cynthia Maeto; Ana María Rodríguez; María Pía Holgado; Juliana Falivene; María Magdalena Gherardi
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.